SARS-CoV Infection

Infectious Disease·MeSH: Severe Acute Respiratory Syndrome

7 drugs in development·1 company·3 clinical trials

Drug Pipeline by Phase

Approved(3)

Drug	Company
covid-19 vaccine	NOVAVAX INC (NVAX)
r21/matrix-m	NOVAVAX INC (NVAX)
r21/matrix-m adjuvant malaria vaccine	NOVAVAX INC (NVAX)

Phase 3(3)

Drug	Company
covid-19-influenza vaccine candidate	NOVAVAX INC (NVAX)
h5n1 avian pandemic influenza vaccine candidate	NOVAVAX INC (NVAX)
stand-alone influenza vaccine candidate	NOVAVAX INC (NVAX)

Phase 1/Phase 2(1)

Drug	Company
icc vaccine	NOVAVAX INC (NVAX)

BioSniper tracks 7 drugs in development for SARS-CoV Infection across 1 company.

There are 3 clinical trials targeting SARS-CoV Infection tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.